Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages.

Febvre-James M, Lecureur V, Augagneur Y, Mayati A, Fardel O.

Int Immunopharmacol. 2018 Jan;54:354-365. doi: 10.1016/j.intimp.2017.11.032. Epub 2017 Dec 1.

PMID:
29202299
2.

The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes.

Febvre-James M, Bruyère A, Le Vée M, Fardel O.

Drug Metab Dispos. 2018 Feb;46(2):131-140. doi: 10.1124/dmd.117.078048. Epub 2017 Nov 21.

PMID:
29162613

Supplemental Content

Loading ...
Support Center